Ratan Capital Management’s Relay Therapeutics RLAY Stock Holding History

Ratan Capital Management’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-50,000	Closed	-$1.54M	–	58
2021 Q4	$1.54M	Buy	50,000 +2,000	+4%	+$63.2K	0.23%	45
2021 Q3	$1.51M	Sell	48,000 -32,000	-40%	-$1.08M	0.2%	62
2021 Q2	$2.93M	Sell	80,000 -25,000	-24%	-$824K	0.25%	66
2021 Q1	$3.63M	Buy	105,000 +35,000	+50%	+$1.52M	0.4%	60
2020 Q4	$2.91M	Hold	70,000	–	–	0.34%	74
2020 Q3	$2.98M	Buy	+70,000	New	+$2.67M	0.44%	62

Other funds holding RLAY

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Ratan Capital Management's RLAY Position: Q1 2022 in Review

Ratan Capital Management sold out of Relay Therapeutics (RLAY) in Q1 2022, closing a stake of 50,000 shares — an estimated $1.54M sold.

Ratan Capital Management first reported a position in RLAY in Q3 2020 and held it in 6 quarters. The position peaked at $3.63M in Q1 2021. 140 funds tracked by Wall St. Rank hold RLAY as of Q1 2022.

Ratan Capital Management reported no remaining Relay Therapeutics position as of Q1 2022 after selling out during the quarter.
Ratan Capital Management sold 50,000 Relay Therapeutics shares in Q1 2022, an estimated $1.54M.
Ratan Capital Management first reported a position in Relay Therapeutics in Q3 2020 and held it in 6 quarters.
Ratan Capital Management's Relay Therapeutics position peaked at $3.63M in Q1 2021.
140 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2022.

Based on Ratan Capital Management's 13F filing for Q1 2022, filed 16 May 2022.